An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects.

Source:http://linkedlifedata.com/resource/pubmed/id/19393851

Download in:

View as

General Info

PMID
19393851